About ExThera Medical
ExThera Medical is a company based in Berkeley (United States) founded in 2007 by Robert Ward.. ExThera Medical has raised $54.59 million across 5 funding rounds from investors including Fresenius Medical Care. The company has 23 employees as of December 31, 2022. ExThera Medical offers products and services including Seraph 100 and ONCObind. ExThera Medical operates in a competitive market with competitors including Hemotune, Medcura, Lindis Blood Care, CytoPherx and Arteriocyte, among others.
- Headquarter Berkeley, United States
- Employees 23 as on 31 Dec, 2022
- Founders Robert Ward
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Exthera Medical Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$54.59 M (USD)
in 5 rounds
-
Latest Funding Round
$6.71 M (USD), Series C
Sep 10, 2021
- Investors
-
Employee Count
23
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ExThera Medical
ExThera Medical offers a comprehensive portfolio of products and services, including Seraph 100 and ONCObind. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Hemoperfusion technology removes pathogens from blood for COVID-19 treatment
Extracorporeal filter targets cancer cells in metastatic patients
Unlock access to complete
Unlock access to complete
Funding Insights of ExThera Medical
ExThera Medical has successfully raised a total of $54.59M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $6.71 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $6.7M
-
First Round
First Round
(24 Apr 2012)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Series C - ExThera Medical | Valuation |
investors |
|
| Mar, 2021 | Amount | Series C - ExThera Medical | Valuation |
investors |
|
| May, 2016 | Amount | Series B - ExThera Medical | Valuation | Fresenius Medical Care |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ExThera Medical
ExThera Medical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Fresenius Medical Care. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Products and services for chronic kidney failure patients are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ExThera Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ExThera Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Exthera Medical Comparisons
Competitors of ExThera Medical
ExThera Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemotune, Medcura, Lindis Blood Care, CytoPherx and Arteriocyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of a device for blood purification
|
|
| domain | founded_year | HQ Location |
Developer of the device for controlling bleeding
|
|
| domain | founded_year | HQ Location |
Innovative solutions for safer blood transfusions are developed.
|
|
| domain | founded_year | HQ Location |
Cytopheresis systems for inflammatory conditions
|
|
| domain | founded_year | HQ Location |
Devices to facilitate blood component and bone marrow transplant
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Exthera Medical
Frequently Asked Questions about ExThera Medical
When was ExThera Medical founded?
ExThera Medical was founded in 2007 and raised its 1st funding round 5 years after it was founded.
Where is ExThera Medical located?
ExThera Medical is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Is ExThera Medical a funded company?
ExThera Medical is a funded company, having raised a total of $54.59M across 5 funding rounds to date. The company's 1st funding round was a Series B of $15.3M, raised on Apr 24, 2012.
How many employees does ExThera Medical have?
As of Dec 31, 2022, the latest employee count at ExThera Medical is 23.
What does ExThera Medical do?
ExThera Medical was founded in 2007 in Berkeley, United States, as a medical devices company. Focus is placed on rapid treatment of bloodstream infections and pathogen reduction in blood banking. The first product, Seraph Microbind Affinity Blood Filter, has been developed and advanced to the clinical research stage. Pathogens and toxins are captured on a biomimetic surface as blood passes through the device, removing them from the bloodstream.
Who are the top competitors of ExThera Medical?
ExThera Medical's top competitors include Medcura, Lindis Blood Care and ArtBlood.
What products or services does ExThera Medical offer?
ExThera Medical offers Seraph 100 and ONCObind.
Who are ExThera Medical's investors?
ExThera Medical has 1 investor. Key investors include Fresenius Medical Care.